These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1069990)

  • 1. Amino-terminal sequences of two polypeptides from human serum with nonsuppressible insulin-like and cell-growth-promoting activities: evidence for structural homology with insulin B chain.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Dec; 73(12):4379-81. PubMed ID: 1069990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II.
    Rinderknecht E; Humbel RE
    Proc Natl Acad Sci U S A; 1976 Jul; 73(7):2365-9. PubMed ID: 1065887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein.
    Zapf J; Schoenle E; Jagars G; Sand I; Grunwald J; Froesch ER
    J Clin Invest; 1979 May; 63(5):1077-84. PubMed ID: 447829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)].
    Froesch ER; Zapf J
    Ann Endocrinol (Paris); 1980; 41(6):502-11. PubMed ID: 7018376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of serum nonsuppressible insulin-like activity (NSILA) in wound healing. I. Influence of thyroparathyroidectomy on serum NSILA and wound healing in the rat.
    Poffenbarger PL; Haberal MA
    Surgery; 1976 Nov; 80(5):608-16. PubMed ID: 982280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preferential association of the insulin-like growth factors I and II with metabolically inactive and active carrier-bound complexes in serum.
    Cornell HJ; Enberg G; Herington AC
    Biochem J; 1987 Feb; 241(3):745-50. PubMed ID: 3593220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A bioassay for NSILA-S in individual serum samples and its relationship to somatotropin.
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    J Clin Endocrinol Metab; 1976 Nov; 43(5):1164-9. PubMed ID: 993319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioimmunoassay for non-suppressible insulin-like activity.
    Reber K; Liske R
    Horm Res; 1976; 7(4-5):201-13. PubMed ID: 1017791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of the acid-ethanol soluble component of non-suppressible insulin-like activity in untreated and treated streptozotocin-diabetic rats.
    Franklin RC; Rennie GC; Cameron DP
    J Endocrinol; 1979 Jun; 81(3):331-7. PubMed ID: 469463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo.
    Kaufmann U; Zapf J; Torretti B; Froesch ER
    J Clin Endocrinol Metab; 1977 Jan; 44(1):160-6. PubMed ID: 833254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsuppressible insulin-like activity (NSILA). II. Regulation of serum concentrations by growth hormone and insulin.
    Heinrich UE; Schalch DS; Koch JG; Johnson CJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):672-8. PubMed ID: 573281
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonsuppressible insulinlike activity (NSILA) and the glucose dyshomeostasis of agonal sepsis.
    Viray RE; Filkins JP
    Adv Shock Res; 1983; 9():31-41. PubMed ID: 6349307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonsuppressible insulin-like activity (NSILA). I. Development of a new sensitive competitive protein-binding assay for determination of serum levels.
    Schalch DS; Heinrich UE; Koch JG; Johnson CJ; Schlueter RJ
    J Clin Endocrinol Metab; 1978 Apr; 46(4):664-71. PubMed ID: 755052
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of a specific inhibitor of nonsuppressible insulin-like activity in a partially purified human serum fraction.
    Herington AC; Kuffer AD
    Endocrinology; 1981 Nov; 109(5):1634-40. PubMed ID: 7297496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocrine influences on serum acid-ethanol soluble non-suppressible in insulin-like activity (NSILA-S).
    Franklin RC; Rennie GC; Burger HG; Cameron DP
    Clin Endocrinol (Oxf); 1980 Feb; 12(2):127-36. PubMed ID: 6772355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From insulin and insulin-like activity to the insulin superfamily of growth-promoting peptides: a 20th-century odyssey.
    Blumenthal S
    Perspect Biol Med; 2010; 53(4):491-508. PubMed ID: 21037404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for a biologically active, carrier-bound form of non-suppressible insulin-like activity (NSILA) in human serum.
    Cornell HJ; Herington AC
    Int J Biochem; 1983; 15(4):553-8. PubMed ID: 6852354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart.
    Meuli C; Zapf J; Froesch ER
    Diabetologia; 1978 Apr; 14(4):255-9. PubMed ID: 640301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation between carrier-bound forms of non-suppressible insulin-like activity (NSILA) in serum.
    Cornell HJ; Bistrin M; Herington AC
    Int J Biochem; 1985; 17(9):1003-8. PubMed ID: 4065403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonsuppressible insulin-like activity in rat organs as detected by fluorescent antibody and radioimmunoassay techniques.
    Liske R; Reber K
    Horm Res; 1976; 7(4-5):214-7. PubMed ID: 797645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.